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Abstract
Control of polyene macrolide production in Streptomyces natalensis is mediated by the transcriptional activator PimR. This
regulator combines an N-terminal domain corresponding to the Streptomyces antibiotic regulatory protein (SARP) family of
transcriptional activators with a C-terminal half homologous to guanylate cyclases and large ATP-binding regulators of the
LuxR family. The PimR SARP domain (PimR
SARP) was expressed in Escherichia coli as a glutathione S-transferase (GST)–fused
protein. Electrophoretic mobility shift assays showed that GST-PimR
SARP binds a single target, the intergenic region between
the regulatory genes pimR and pimMs in the pimaricin cluster. The PimR
SARP-binding site was investigated by DNaseI
protection studies, revealing that it contains three heptameric direct repeats adjusting to the consensus 59-CGGCAAG-39.
Transcription start points of pimM and pimR promoters were identified by 59-RACE, revealing that unlike other SARPs,
PimR
SARP does not interact with the -35 region of its target promoter. Quantitative transcriptional analysis of these
regulatory genes on mutants on each of them has allowed the identification of the pimM promoter as the transcriptional
target for PimR. Furthermore, the constitutive expression of pimM restored pimaricin production in a pimaricin-deficient
strain carrying a deletion mutant of pimR. These results reveal that PimR exerts its positive effect on pimaricin production by
controlling pimM expression level, a regulator whose gene product activates transcription from eight different promoters of
pimaricin structural genes directly.
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Introduction
Streptomycetes are well-known for their ability to produce
a great variety of secondary metabolites including therapeutic
molecules like polyene macrolide antibiotics. These constitute
a large group of antifungal agents [1,2] whose production, occurs
in a growth-phase-dependent manner, at the transition between
the rapid growth phase and the stationary growth phase [3]. The
control of secondary metabolite production is a rather complex
process involving multiple levels of intertwined regulation.
Typically the lowest level is composed by pathway-specific
transcriptional regulators, which are encoded within the respective
biosynthetic gene cluster.
PimR was the first pathway-specific transcriptional regulator of
pimaricin biosynthesis to be described [4]. Pimaricin, an
archetypical representative of small glycosylated polyenes, is
a tetraene produced by Streptomyces natalensis [5] whose biosynthetic
gene cluster [6–11], and other factors regulating production
[12,13] have been characterized. PimR is a transcriptional
activator (its inactivation from the S. natalensis chromosome
resulted in complete loss of pimaricin production [4]) with
a peculiar architecture. It contains an N-terminal SARP (Strep-
tomyces Antibiotic Regulatory Protein) domain [14] with a C-
terminal half homologous to guanylate cyclases and LAL
regulators (Large ATP-binding regulators of the LuxR family)
[15]. The C-terminal half includes the ATP/GTP binding AAA
domain characteristic of these protein families but lacks the
signature sequence at the N-terminus of guanylate cyclases or the
LuxR-type helix-turn-helix motif for DNA binding present at the
C-terminus of LAL regulators. PimR was the first of its class to be
described, and constitutes the prototype of a new class of
regulators. Members of this class include the regulator PteR from
S. avermitilis located in the biosynthetic gene cluster for the
pentaene filipin [16], the nikkomycin activator in S. ansochromogenes
SanG [17], or the polyoxin regulator in S. cacaoi PolR [18] which is
directly controlled by PolY [19].
SARPs belong to the OmpR family of transcriptional regulators
[20]. These proteins have their DNA binding domain at the N-
terminus but act as transcriptional activators, unlike most other
regulators with such a layout acting as transcriptional repressors
[21]. LAL regulators constitute a poorly studied family of
transcriptional modulators. Several regulators of this class have
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clusters from actinomycetes [22,23], thus they have been
considered pathway-specific regulators, but it is conceivable that
LAL regulators could play a role in higher steps of the regulatory
cascade [24].
PimM constitutes the second pathway-specific transcriptional
regulator of pimaricin biosynthesis [25]. It also has a peculiar
architecture, combining an N-terminal PAS sensory domain [26]
with a C-terminal helix-turn-helix motif of the LuxR type for
DNA binding. PAS domains were first found in eukaryotes, and
were named after their homology to the Drosophila period protein
(Per), the aryl hydrocarbon receptor nuclear translocator protein
(ARNT) and the Drosophila single minded protein (Sim). Recently,
we characterized the mode of action of PimM at the molecular
level, and determined that it binds eight promoters of pimaricin
genes [27]. The PimM regulatory model is especially attractive
because PimM orthologous regulatory proteins are encoded in all
known biosynthetic gene clusters of antifungal polyketides, and all
these regulators are functionally conserved [28].
Previous gene expression analyses by reverse transcriptase-
polymerase chain reaction (RT-PCR) of the pimaricin gene cluster
in a strain carrying a frameshift mutation of the pimR gene
suggested the targets for the PimR regulatory protein [4].
According to these analyses very low level transcription of key
enzyme-encoding genes for pimaricinolide construction except for
the mutant pimR gene was observed. This result explained the lack
of pimaricin production in the mutant, and demonstrated that this
regulator activates the transcription of the majority of genes
belonging to the pimaricin gene cluster but not its own
transcription [4]. Similarly, gene expression analyses by RT-
PCR in a strain carrying a deletion of the pimM gene revealed its
targets, and suggested, erroneously, that both regulators were
acting on independent regulatory circuits [25]. Now, electropho-
retic mobility shift assays (EMSA), footprinting analyses, quanti-
tative RT-PCR and gene promoter replacement experiments have
been used for determining the binding site for PimR and its
transcriptional target, thereby elucidating the hierarchical re-
lationship between PimR and PimM.
Results
Complete deletion of pimR from the S. natalensis
chromosome blocked pimaricin biosynthesis, and gene
complementation restored antifungal production
We had previously constructed a S. natalensis DpimR mutant
strain lacking the internal ATP/GTP-binding site of this regulator,
but retaining the N-terminal SARP binding domain [4]. In order
to avoid interference of this DNA-binding domain with future in
vivo studies, we decided to construct a new DpimR mutant where
the gene was completely deleted. For that purpose we used the
REDIRECT gene replacement technology as indicated in
Materials and Methods. Double-crossover mutants were screened
by spectinomycin resistance and kanamycin sensitivity. These
(about 1%) were verified by both PCR and Southern blot analysis
(not shown).
The new strain S. natalensis DpimR2 had growth and morpho-
logical characteristics identical to those of S. natalensis wild type
when grown on solid or liquid media, suggesting that PimR has no
role in bacterial growth or differentiation. The spore counts of
both strains were similar after growth for 9 days at 30uC on TBO
plates. The spores of both strains were serially diluted and plated
on minimal medium to check their viability, finding no differences
between the two strains. Both strains grew well in liquid minimal
medium, showing an identical growth curve.
The fermentation broth produced by the new mutant strain, S.
natalensis DpimR2, was extracted with methanol and analyzed for
the presence of pimaricin. High performance liquid chromatog-
raphy (HPLC) assays indicated that no pimaricin was being
produced by the mutant strain DpimR2 (Fig. S1).
To confirm that the deletion of pimR was directly responsible for
the abolition of pimaricin production, we complemented the
mutant with pimR. A DNA fragment containing pimR plus its
putative promoter region was inserted into the integrative vector
pSET152, giving rise to pSETpimR (see Materials and Methods).
The plasmid was then transferred from E. coli ET12567
[pUZ8002] to S. natalensis DpimR2 by conjugation. pSET152 was
also introduced into S. natalensis wild type as control. Introduction
of pSETpimR restored pimaricin biosynthesis to the control levels
(Fig. S1). These results were fully consistent with those obtained
upon deletion of the pimR gene, and confirm the involvement of
PimR in pimaricin biosynthesis.
Heterologous expression of the DNA-binding SARP
domain
Heterologous expression of PimR in E. coli was first attempted
as both N-terminal, and C-terminal 6xHis fusion proteins to
facilitate in vitro analysis of its function. The coding sequence of
pimR was cloned into the expression vectors pQE30 and pQE70
(Qiagen), and transformed into E. coli BL21(DE3) for expression.
Both systems yielded insoluble protein after induction with IPTG.
PimR was then expressed as a glutathione S-transferase (GST)-
fusion protein following cloning into the pGEX-2T expression
vector and transformation into E. coli BL21(DE3). Again, the
PimR protein obtained was largely insoluble.
These unsuccesful results, which we think could be due to the
unusually large size (about 130 kDa) of the protein and the
presence in its structure of several putative transmembrane
domains, prompted us to express just the SARP DNA-binding
domain. Hence, this DNA binding domain was expressed as
a 56 kDa glutathione S-transferase (GST)-fusion protein following
cloning into the pGEX-2T vector and transformation into E. coli
BL21(DE3). A significant proportion of GST–PimR
SARP fusion
protein was found in the soluble fraction, and was purified by
glutathione affinity chromatography (Fig. S2). The identity of the
fusion protein was verified by MALDI-TOF MS. Purification
yielded 4.4 mg of pure protein per liter of E. coli culture. This
protein was further concentrated by filtration in Amicon tubes.
PimR
SARP could not be separated from GST by using thrombin
since, regardless of lacking canonical proteolytic sites in its
sequence, it got completely degraded upon digestion. However,
given that GST-tagged proteins have been successfully used in
EMSAs [27], the fusion protein GST- PimR
SARP was used for in
vitro experiments.
PimR
SARP binds a single target in the pimaricin gene
cluster
As shown in Figure 1, 12 different DNA probes containing all
the known promoter regions of the pimaricin gene cluster (Fig. 1A)
were tested in the search for direct interactions with the SARP
domain of PimR by EMSA. No interaction was observed for any
of the probes that contained the promoter regions of the
biosynthetic pimaricin genes, the non-transcriptional regulatory
genes, or the transporters (Fig. 1B). However, a strong band
shifting was observed with the probe containing the pimM-pimR
intergenic region (Fig. 1B). In this case, a progressive decrease in
the amount of added GST-PimR
SARP protein resulted in the
progressive decrease of the intensity of the retarded band (Fig. 2A).
PimR Activates Polyene Production via PimM Control
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by the GST moiety of the fusion protein, an EMSA assay was
performed in the same conditions but using pure GST (60 mM)
instead of GST-PimR
SARP. This experiment was negative,
excluding a possible binding of the GST protein to the promoter,
(Fig. 2B).
To ensure that the binding of GST-PimR
SARP to pimM-Rp was
specific, competition experiments in which different unlabeled
probes were added to the usual binding reaction were performed.
As shown in Figure 2C, the addition of an increasing amount of
pimM-Rp unlabeled probe resulted in a progressive decrease of the
retarded band intensity. In contrast, the addition of increasing
amounts of an unlabeled promoter region such as pimJp, failed to
diminish the intensity of the retardation band (Fig. 2D).
Taken together, these results indicate that GST-PimR
SARP
interacts directly with the intergenic region between pimR and
pimM, and does it in a specific way.
DNaseI protection studies reveal PimR
SARP binding site
To determine the PimR
SARP binding sequence, the promoter
region shown above to be retarded in EMSA was studied by
DNase I protection analysis. GST–PimR
SARP protein (10 mM) was
tested using a 59-end fluorescein-labeled DNA fragment. All
analyses were carried out by triplicate.
Results showed a major protected region extending for 35 bp of
pimM coding strand (Fig. 3), in agreement with the appearance of
one retardation band in EMSA experiments. This protected
region is located at nucleotide positions 2276 to 2242 with
respect to the pimM translational ATG start site (positions 2155 to
2122 from the pimR translational start site). Interestingly, the
nucleotide sequence of this protected region (TGGCAA-
GaaagCGGCAGGtgttCGGCAAGgattcc) contains three hepta-
meric direct repeats (in uppercase) with 4 bp spacers. Heptameric
repeats are typical for SARP-binding targets, and in this case are
almost coincident with those recognized by the nikkomycin
regulator SanG [29], and the polyoxin activator PolR [18] which
is directly controlled by PolY [19]. Strikingly, while SanG and
Figure 1. Organization of the pimaricin gene cluster and GST-PimR
SARP DNA binding assay results. A) Pointed boxes indicate the
direction of transcription. Transcriptional regulatory genes (pimR and pimM) are indicated in red, other regulators are indicated in purple, and the
polyketide synthase genes in green. The remaining genes (in grey) are involved in polyene tailoring or export. B) Electrophoretic mobility analysis
(EMSA) of GST-PimR
SARP binding to different putative promoter regions. The arrow indicates the DNA–protein complex. Promoter names are
indicated above the picture. All experiments were carried out with 2 ng labeled DNA probe. Left lane, control without protein; right lane, 10 mMo f
GST-PimR
SARP protein.
doi:10.1371/journal.pone.0038536.g001
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SARP binding
region contains three of such repeats.
Some protected nucleotides were also observed downstream the
main protected stretch (Fig. 3). This region also contains two
heptameric direct repeats (aCGGCAGGcgaCGGCAAG), al-
though in this case the spacing is of 3 nucleotides. This feature
might explain the weak protection observed in this region, and also
the absence of an additional retardation band in the EMSA assays.
Figure 2. Binding of GST-PimR
SARP to its target is specific. Analysis by EMSA of the binding of GST-PimR
SARP to the pimR-M promoter region.
Arrows indicate the DNA–protein complexes. All experiments were carried out with 2 ng labeled DNA probe. Lane P, control without protein. A)
Decreasing gradient of protein. Lane 1, 5 mM of protein; lane 2, 2.5 mM; lane 3, 1.25 mM; lane 4, 625 nM; lane 5, 312 nM; lane 6, 160 nM; lane 7,
80 nM; lane 8, 40 nM of protein. B) Control reaction with 10 mM of pure GST protein. C) Competition experiment between labeled pimM-R promoter
and unlabeled pimM-R promoter. The experiment was performed with 1.25 mM of GST-PimR
SARP. D) Competition experiment between pimM-Rp and
pimJp. Note that 200-fold-higher concentrations of unlabeled pimJp competitor DNA failed to decrease the intensities of the pimM-Rp retardation
bands. The experiment was performed with 80 nM of GST-PimR
SARP.
doi:10.1371/journal.pone.0038536.g002
Figure 3. Identification of binding sites. The upper electropherogram (blue line) is the control reaction. The main protected nucleotide
sequence is boxed in grey, a secondary group of protected nucleotides is boxed in white. Sequencing reactions are included. Coordinates are from
the translation start point.
doi:10.1371/journal.pone.0038536.g003
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To determine the transcriptional start sites of pimM and pimR
promoters, 59-RACE experiments were carried out. Once the +1
sites were known, the corresponding 210 and 235 boxes of each
promoter were established by comparing them to the matrices
reported by Bourn and Babb [30] for Streptomyces that take into
account the nucleotides occurring in 13-nucleotide stretches,
including the –10 or –35 consensus hexamers (see Materials and
Methods). Results are summarized in Fig. 4.
A single RACE product of approximately 400 bp was observed
for pimM. The pimM transcription start point (TSP) is located at an
adenine at 148 bp upstream from the ATG codon. Analysis of the
region upstream of the TSP revealed that the 210 box with the
highest score to the consensus Streptomyces was CACAAT (score
3.51), centered at 10 nucleotides from the start site. A search using
combined class C–class A matrices [30] revealed a 235 box
CCAGGA separated by 19 nucleotides, with a score of 3.71.
Noteworthy, the protected region observed in the footprinting
assays is 93 nt away from the TSP site, and does not cover the
235 hexamer box (Fig. 4).
For pimR, a single RACE product of ca. 350 bp was observed.
Its TSP corresponds to a guanine located 63 bp upstream from the
ATG codon (Fig. 4). The sequence TCCACA (score 1.02)
centered at position 210, constitutes the 210 consensus, and
a 235 box AAGGCG (score 2.77) was identified at 17 nt distance.
As in the former case, the protected region lays 58 nt upstream
from the TSP site, and does not cover the 235 hexamer box of the
promoter (Fig. 4). This is unsual since DNA-binding domains of
SARP regulators always bind sequences that overlap the 235
hexamer of the promoters they control [18,29,31–33].
PimR is the hierarchical superior that controls pimM
transcription
Above results indicated that PimR interacts directly with the
pimM-pimR intergenic region, binding an operator containing
heptameric direct repeats, which is typical of SARP-binding
targets [33], but unlike other SARPs this sequence did not overlap
the 235 element of any of the two promoters present in that
region. In order to determine the target promoter of PimR, we
studied the expression of both pimR and pimM genes in S. natalensis
DpimR2, and also in a DpimM mutant [25], and compared them
with the parental strain.
Total RNA was prepared from S. natalensis wild type and
mutants DpimR2 and DpimM after growth for 48 h (when
pimaricin is actively produced [6]) and used as template for gene
expression analysis by quantitative RT-PCR. The expression levels
of pimR and pimM genes in both mutants in relation to those of the
wild-type strain (assigned a relative value of 1) are shown in
Figure 5. Transcription levels of 0.84 and 1.29 were found for
pimR in the mutants DpimR2 and DpimM respectively (Fig. 5)
indicating that the expression of this regulator is not affected by
any of the mutations in a statistically significant level (see Materials
and Methods), and confirming that PimR is not autoregulated.
However, when we analysed pimM transcription in the same
strains, while its expression was not affected (relative value of 0.72)
in S. natalensis DpimM, indicating that PimM is not autoregulated, it
was dramatically reduced in the DpimR2 mutant, showing a relative
value of 0.011 (Fig. 5). This means 90-fold less expression than in
the parental strain, and clearly indicates that pimM promoter is the
transcriptional target of PimR.
In order to corroborate this finding, we introduced pimM, under
the control of a constitutive promoter, into S. natalensis DpimR2. We
used the ermE* promoter, an upregulated variant of ermE promoter
that has been frequently deployed as a strong constitutive
promoter for gene expression in Streptomyces. For this purpose,
a DNA fragment containing pimM plus its ribosomal binding site
was inserted into the integrative vector pIB139 [34], giving rise to
pCPpimM (see Materials and Methods). This construct, in which
pimM is placed under the control of the ermE* promoter but uses its
own ribosome binding site, was then transferred from E. coli
ET12567 [pUZ8002] to S. natalensis DpimR2. The constitutive
expression of pimM bypassed the pimR mutation and restored
pimaricin biosynthesis (Fig. 6), thus demonstrating that the pimM
promoter is the unique target for PimR.
Figure 4. Transcriptional start sites of pimR and pimM. The position of the transcriptional start site was determined by 59 RACE. The putative
210 and 235 hexanucleotides are boxed. Scores resulting from the comparison to the matrices reported by Bourn and Babb [30] for Streptomyces are
indicated between brackets. The TSP is indicated by a bent arrow and bold type letter. Nucleotides showing homology with the 16S RNA, which
could form a ribosome-binding site, are framed with a box labeled RBS. The start codon is shown in a black box. The main protected nucleotide
sequence is indicated with a shaded box, and the secondary group of protected nucleotides is boxed in white. The heptameric repeats are indicated
in bold.
doi:10.1371/journal.pone.0038536.g004
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The regulator PimR contains an N-terminal domain corre-
sponding to the SARP family of transcriptional activators with a C-
terminal half homologous to guanylate cyclases and large ATP-
binding regulators of the LuxR family. Regulators with a similar
architecture include the putative biosynthetic regulator PteR
involved in filipin biosynthesis in S. avermitilis [16], the nikkomycin
activator SanG in S. ansochromogenes [17], and the polyoxin
regulator in S. cacaoi PolR [18]. Filipin is a polyene macrolide
while nikkomycins and polyoxins are peptidyl nucleoside anti-
biotics. Interestingly, although these compounds are structurally
different, and have a different mode of action [1], all of them are
effective antifungals. It seems plausible that these regulators with
highly similar architectures could share similar regulatory
mechanisms. Since their only common feature is their antifungal
activity, it is tempting to speculate that their domain arrangement
might be related with the detection of common signals involved in
the triggering of antifungal production.
Electrophoretic mobility shift assays have been used here to
prove the direct binding of the PimR SARP domain to the
intergenic region between pimM and pimR, and that this is the
unique target of the regulator within the pimaricin biosynthetic
gene cluster. Quantitative RT-PCR was then used to show the
dependence of pimM expression on the presence of intact PimR,
thus placing the latter protein above PimM in regulatory
hierarchy. This result was confirmed by replacing pimM promoter
by a constitutive promoter, such as ermE*, in the pimaricin-
deficient strain S. natalensis DpimR2, and restoration of pimaricin
production. Taken together, these results demonstrate that the
positive effect exerted by PimR on pimaricin production takes
place via the regulation of pimM expression level.
Analysis of the protected sequence in the DNase I protection
assays revealed PimR
SARP binding site, showing that it contains
three heptameric direct repeats of the consensus CGGCAAG with
4 bp spacers. Operators with heptameric repeats separated by
four-nucleotide spacers positioned on the same face of the DNA
helix (one complete turn of the DNA helix) are typical of SARP
regulators [14], although the precise consensus nucleotide
sequence of the heptamer, and the number of repetitions, varies
depending on the regulator [33]. Strikingly, the consensus
heptamer for PimR
SARP is identical to those of SanG [29] and
PolR [18], although in these cases only two heptameric repeats are
present in the operator. It could be argued that the lack of the rest
of the protein might be affecting specificity and degree of binding.
In our opinion, this is unlikely, since in other multidomain SARP
regulators such as AfsR, it has been demonstrated that the
specificity of binding relies exclusively in the SARP domain [33].
However, at this stage such possibility cannot be excluded.
Analysis of PimR
SARP binding site together with the identifica-
tion of the transcriptional start points of pimM and pimR promoters
revealed that unlike all SARPs, including PimR counterparts
SanG and PolR, PimR does not interact with the 235 region of its
target promoter. Instead, its binding site is located at 55
nucleotides upstream of that element. To our knowledge, this is
unprecedented for a SARP regulator, since these regulators always
interact with the 235 element of target promoters [33]. This result
must be taken with some reservation, given that our assays have
been carried out with just the DNA-binding domain of PimR.
However, no heptameric repeats are present overlapping the 235
hexamer of pimM promoter.
PimR-DNA interaction is presumed to enable protein-protein
contacts between RNA polymerase and PimR as an important
functional aspect in transcriptional activation. This would
correspond to a Class I activation mechanism where PimR would
contact the C-terminal domain of the RNA polymerase a subunit,
resulting in recruitment of the RNA polymerase holoenzyme to
the promoter [35]. Future experimental analyses will be required
to test this hypothesis.
Figure 5. PimR controls pimM transcription. Gene expression was assessed using quantitative RT-PCR with the primers indicated in Table S2.
The relative values are referred to 1, the assigned relative value for the expression of each gene in S. natalensis ATCC 27448. The expression of rrnA1
(encoding 16S rRNA) was used as control. Error bars were calculated by measuring the standard deviation among two biological and six technical
replicates of each sample. The mRNA templates were from 48 h cultures grown in YEME medium without sucrose. Fold change values are indicated
below.
doi:10.1371/journal.pone.0038536.g005
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the footprinting assays is intriguing. This region contains two
consensus heptameric repeats, but the spacer is of only 3
nucleotides, thus conforming 10 bp repeating units instead of the
classical 11 bp SARP binding sequences [14]. In any case, this
weak-protected sequence is still far away from the 235 element of
the pimM promoter (18 pb) and does not overlap it, so its presence
and hypothetical functionality (that will be the focus of future
experimental efforts) would not essentially alter the proposed
transcriptional activation model.
Notably, unlike its counterparts SanG and PolR, which exert
their regulatory effects by directly interacting with promoters of
structural genes [18,29], PimR acts as a regulator of regulators,
modulating the expression level of pimM. PimM, in turn, controls
the expression of the genes pimK, pimS2S3S4, pimI, pimJ, pimAB,
pimE, pimS1, and pimD through direct binding to the promoters of
these genes [27]. Taken together, these results reflect a very clear
regulatory cascade, in which PimR regulates the transcription of
pimM, which in turn activates the transcription of pimaricin
biosynthetic genes from eight different promoters [27]. In this
model, PimR and PimM represent two different but consecutive
points of control for pimaricin production. Although some cases of
SARPs acting as regulators of regulators are known [36], PimR
represents the first example belonging to the SARP-LAL subfamily
of regulatory proteins. The different type of targets between PimR
and its counterparts SanG and PolR illustrates the flexibility in
which evolution is able to arrange the components of regulatory
cascades in order to achieve the best adaptive responses to
environmental challenges.
Unlike PimM, which binds multiple promoters and whose
expression constitutes a bottleneck for pimaricin production [28],
PimR has a single target, so it is unlikely that its expression could
constitute a bottleneck for biosynthesis. In fact, the introduction of
an extra copy of pimR into S. natalensis has no effect on pimaricin
production [37]. In contrast, sanG [17] or polR [18] gene copy
increments boost the production of nikkomycins and polyoxins,
respectively.
Figure 6. Constitutive expression of pimM in S. natalensis DpimR2 results in restoration of pimaricin production. Comparison of HPLC
analyses of methanol-extracted broths from S. natalensis wild type (top), DpimR2 (middle), and DpimR2 + pCPpimM strains (bottom). Detection was
carried out at A304nm. Chromatographic peaks corresponding to pimaricin and 4,5-deepoxypimaricin are indicated by arrows.
doi:10.1371/journal.pone.0038536.g006
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GaaagCGGCAGGtgttCGGCAAG) is exactly conserved in the
intergenic region between between scnRII and scnRI in the
pimaricin gene cluster of S. chattanoogensis (pimM and pimR
counterparts, respectively [38]), and also between pteF and pteR,
the corresponding counterparts in the filipin gene cluster of S.
avermitilis, including the inter-heptamer nucleotides. These genes
are also arranged divergently in the chromosome. It is thus likely
that the hierarchical relationship between PimR and PimM could
be conserved in other polyene regulatory pathways.
Materials and Methods
Bacterial strains and cultivation
S. natalensis ATCC 27448 was routinely grown in YEME
medium without sucrose [39]. Sporulation was achieved in TBO
medium [39] at 30uC. Escherichia coli strain DH5a was used as
a host for DNA manipulation. E. coli BL21 (DE3) was used for
expression studies. E. coli ET12567 [pUZ8002] was used as donor
in intergeneric conjugations.
Plasmids and DNA manipulation procedures
pUC19 (New England Biolabs) was used as the routine cloning
vector, pGEX-2T (GE-Healthcare) was the vector used to
construct expression plasmids, and pSET152 (Am
R, pUC18
replicon, WC31 attP [40]) and pIB139 [34] the vectors used for
gene complementation. Plasmid and genomic DNA preparation,
DNA digestion, fragment isolation, and transformation of E. coli
were performed by standard procedures [41]. Polymerase chain
reactions were carried out using Phusion DNA polymerase as
described by the enzyme supplier (Finnzymes). DNA sequencing
was accomplished by the dideoxynucleotide chain-termination
method using the Perkin Elmer Amplitaq Gold Big Dye-
terminator sequencing system with an Applied Biosystems ABI
3130 DNA genetic analyzer (Foster City, CA., USA). DNA
delivery into Streptomyces strains was accomplished by intergeneric
conjugation as described [42].
Deletion of pimR
Deletion of pimR of S. natalensis was made by replacing the wild-
type gene with a cassette containing a spectinomycin selective
marker using a PCR based system [43]. The plasmid pIJ778
containing the spectinomycin resistance gene (aadA) and the oriT
replication origin was used as a template. The mutant was
constructed using the oligonucleotides 59-cagtcagccatatccgcga-
gaggcacggggaccgtaatgATTCCGGGGATCCGTCGACC-39 and
59-cctccctttgatgtcacggcgggcgtcgggaaatccttatGTAGGCTG-
GAGCTGCTTC-39 as the forward and reverse primers re-
spectively (the sequence identical to the DNA segment upstream
from the start codon of pimR is underlined and in lower case and
the sequence identical to the segment downstream from the stop
codon of pimR is in lower case italics). These two long PCR
primers (59 nt and 58 nt) were designed to produce a deletion of
pimR just after its start codon leaving only its stop codon behind.
The 39 sequence of each primer matches the right or left end of the
disruption cassette (the sequence is shown uppercase in both
primers). The extended resistance cassette was amplified by PCR
and E. coli BW25113/pIJ790 bearing cosmid P6 [39] was electro-
transformed with this cassette. The isolated mutant cosmid was
introduced into non-methylating E. coli ET12567 containing the
RP4 derivative pUZ8002. The mutant cosmid was then trans-
ferred to S. natalensis by intergeneric conjugation [42]. Double
cross-over exconjugants were screened for their kanamycin
sensitivity and spectinomycin resistance.
Constructs for gene complementation
In order to complement DpimR2 replacement mutant, pNAF1
[4] was digested with SacI and KpnI to generate a 3874 bp
fragment which was cloned into the SacI and KpnI sites of pUC18,
resulting in pNAF1B. Separately, pNAF1 was cut with NotI and
SacI to yield a 541 bp fragment which was cloned into the NotI and
SacI sites of pUC18, resulting in pNAF1A. Then, a 538 bp EcoRI
and SacI fragment from pNAF1A was cloned into the same sites of
pNAF1B to generate pNAF3. Finally, a 4403 bp BamHI DNA
fragment containing the entire pimR gene including its own
promoter was obtained from pNAF3 and ligated into a BamHI-cut
pSET152, to yield pSETpimR. This plasmid was then transferred
by conjugation from E. coli ET12567 [pUZ8002] to the S. natalensis
DPimR2 mutant as previously described [42].
Polyene production assessment
To assay pimaricin in culture broths, 0.5 ml of culture was
extracted with 4 ml of methanol, and further diluted with
methanol to bring the absorbance at 319 nm in the range of 0.1
to 0.4 units. Control solutions of pure pimaricin (Sigma) were used
as control. To confirm the identity of pimaricin, an UV-visible
absorption spectrum (absorption peaks at 319, 304, 291 and
281 nm) was routinely determined in a Hitachi U-2900 spectro-
photometer. Quantitative determination of pimaricin was per-
formed as previously described [44], using a Mediterranea Sea
C18 column (4.66150 mm, particle size, 3 mm) (Teknokroma).
Expression and purification of GST fusion protein
PimR SARP domain (PimR
SARP) was overexpressed in E. coli
BL21(DE3) cells as a GST fusion protein. Expression vector was
constructed based on the pGEX-2T (GE-Healthcare) vector using
PCR. The forward primer used (59-TACAGGATC-
CATGCCCGCACCACCGACCGC-39) introduced a unique
BamHI site at the 59 end of the gene, while the reverse primer
(59-TACGGAATTCTTCTAGGGGGCGCTCGCTCC-39) car-
ries an EcoRI site. This generates a GST-PimR
SARP fusion protein
which includes the first 281 residues of PimR (SARP domain). The
amplified DNA fragment was digested with BamHI and EcoRI
and cloned into the same sites of pGEX-2T to generate
pPimR
SARP. The amplified DNA fragment was sequenced from
the expression vector in order to discard any mistakes introduced
by the DNA polymerase.
E. coli transformants were grown at 18uC in 600 ml LB medium
containing 100 mg/ml of ampicillin until an OD600 of 0.7 was
reached and then induced by adding isopropyl 1-thio-b-D-
galactopyranoside to a final concentration of 0.1 mM, and grown
for an additional 14 h at 18uC. Cells were harvested, resuspended
in PBS buffer pH 7.3, and lysed by sonication using an ultrasonic
processor XL apparatus (Misonix Inc.). The insoluble material was
separated by centrifugation, and the soluble fraction was filtered
and applied to a Glutathione sepharose 4B (Pharmacia biotech)
column. Protein was eluted with 10 mM reduced glutathione in
50 mM Tris-HCl pH 8.0, and conserved in 20% glycerol at
280uC before use. Protein elution was monitored at 280 nm and
the presence of the fusion protein was assessed by SDS-PAGE.
PimR
SARP could not be separated from GST by using thrombin
since, regardless of lacking canonical proteolytic sites in its
sequence, it got completely degraded upon digestion. However,
given that GST-tagged proteins have been successfully used in
EMSAs [27,45], we decided to use the fusion protein GST-
PimR
SARP for in vitro experiments.
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DNA binding tests were performed by EMSA. The DNA
fragments used for EMSA were amplified by PCR using the
primers as described [27], and labeled at both ends with
digoxigenin with DIG Oligonucleotide 39-End Labeling Kit, 2nd
Generation (Roche Applied Science). Binding assays were
performed with the GST–PimR
SARP protein (40 nM–10 mM)
using the same buffer conditions described by Li et al [18] for the
binding reactions of PolR. The final binding reaction mixture was
10 mM Tris-HCl pH 7.5, 5 mM MgCl2, 2 mM dithiothreitol,
7.8 mM glutathione, 40 mg/ml poly dI-dC, 17% glycerol and
0.5 mg/ml BSA in a final volume of 25 ml.
Footprinting assays
DNase I footprinting assays were performed by the fluorescent
labelling procedure as described in Santos-Aberturas et al. [27],
using the same binding conditions as for the EMSA assays. The
DNA fragment used was the same as the one used for EMSA
experiments, cloned into pUC19, and amplified by PCR using the
universal and reverse primers, one of them labeled with 6-
carboxyfluorescein. The same labeled oligonucleotide served to
prime the sequencing reaction. The PCR product was purified
after agarose-gel electrophoresis and DNA concentrations were
determined with a NanoDrop ND-1000 spectrophotometer
(Thermo Scientific).
DNase I footprinting was performed by incubating 0.28 pmol of
the DNA probe and 10 mM GST–PimR
SARP protein for 10 min
at 30uC. Lyophilized bovine pancreas DNase I (Roche grade I)
was reconstituted in 20 mM Tris HCl pH 7.0, 50 mM NaCl,
100 mg/ml BSA, 1 mM DTT, 10% glycerol to a final concentra-
tion of 2.5610
23 units/ml. Nuclease digestions were carried out
with 0.01 units (4 ml) at 30uC for 1 min and stopped with 120 ml
of 40 mM EDTA in 9 mM Tris HCl pH 8.0. After phenol-
chloroform purification and ethanol precipitation, samples were
loaded in an Applied Biosystems ABI 3130 DNA genetic analyzer
(Foster City, CA., USA). Results were analysed with the PEAK
SCANNER program (Applied Biosystems).
Bioinformatic analysis
Candidate sequences to contain promoters were analyzed using
the Patser algorithm [46], implemented in the web resource
Regulatory Sequence Analysis Tools [47]. The pseudocount value
was set to 10, and the alphabet parameter was adjusted to the GC
content of Streptomyces genome: AT, 0.15; CG, 0.35. The matrices
used to search for regions 235 and 210 were those derived from
the alignments of class C and class A promoters of Bourn and
Babb [30]. To search for a combination of ‘class C–n nucleotides
of separation–class A’, we included n columns of null values in the
combined matrix.
Isolation of total RNA
S. natalensis ATCC 27448 was grown for 48 h in YEME
medium without sucrose (stationary phase of growth), the cultures
were then treated as described elsewhere [48].
Rapid amplification of cDNA ends (RACE)
The 59 ends of transcripts were identified by using a 59 RACE
system for rapid amplification of cDNA ends kit (Invitrogen)
following the manufacturer’s instructions (version 2.0). Briefly, first
strand cDNA synthesis was carried out using 3.7 mg of RNA,
reverse transcriptase, and the gene specific primer (numbers 1 in
supp. Table S1). The cDNA was purified using the SNAP columns
provided in the kit, and poly(dC) tails were added to the 39 ends
using terminal deoxynucleotidyl transferase. PCR amplification of
the tailed cDNA was carried out using the 59 RACE abridged
anchor primer with the first nested primer (numbers 2 in supp.
Table S1). A dilution of the PCR mixture was then subjected to
reamplification using the abridged universal amplification primer
with the second nested primer (numbers 3 in supp. Table S1). The
PCR products were gel-purified and sequenced. When cDNA
tailing with poly(dC) did not permit the identification of the
transcription start point, poly(dA) tails were added to the 39 ends of
cDNA. In these cases, second strand cDNA synthesis was
necessary prior to nested amplifications and was carried out using
the 39 RACE adapter primer (invitrogen). PCR amplification of
the cDNA was then carried out using the abridged universal
amplification primer with the first nested primer (numbers 2 in
supp. Table S1). Final nested amplification was carried out as
before.
Quantitative real-time PCR
Reverse transcription of total RNA was performed on selected
samples with 5 mg of total RNA and 12.5 ng/ml of random
hexamer primer (Invitrogen) ausing SuperScript
TM III reverse
transcriptase (Invitrogen) according to manufacturer’s instructions.
All RNA samples were analyzed with the Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA) and only those
with RIN values [49] raging from 6.5–7.5 were selected. Each
reaction was performed in 20 ml with SYBRH Premix Ex Taq
TM
(TaKaRa), 200–300 nM of each primer and the template cDNA
1:2 diluted and run on a StepOnePlus Real Time PCR system
(Applied Biosystems). Reactions were carried out on two biological
replicates with six technical replicates each and appropriate
controls were included to verify the absence of gDNA contami-
nation in RNA and primer-dimer formation. Primers (see supp.
Table S2) were designed to generate PCR products between 62
and 137 bp, near the 59-end of mRNA using the PRIMER3
software [50]. The PCR reactions were initiated by incubating the
sample at 95uC for 10 min followed by 40 cycles at 95uC for 15 s,
66–70uC (depending of the set of primers used) for 34 s. To check
the specificity of real-time PCR reactions, a DNA melting curve
analysis was performed by holding the sample at 60uC for 60 s
followed by slow ramping of the temperature to 95uC. SYBR
fluorescence was normalized by ROX fluorescence. Baseline and
threshold values were determined by the StepOnePlus software. Ct
values were normalized with respect to 16S rRNA (rrnA1). Relative
changes in gene expression were quantified using the Pfaffl method
[51] and the REST software [52]. The corresponding real-time
PCR efficiency (E) of one cycle in the exponential phase was
calculated according to the equation E 10
[21/slope] [53] using 5-
fold dilutions of genomic DNA raging from 0,013 to 40 ng (n=6
with three replicates for each dilution) with a coefficient of
determination R
2.0,98 (Fig. S3).
Construct for the constitutive expression of pimM
In order to corroborate that pimM promoter was the only target
for PimR, and to establish the hierarchical relationship between
both regulators, we introduced pimM, under the control of
a constitutive promoter, into S. natalensis DpimR2. For that purpose,
a 698 bp DNA fragment containing the entire pimM gene
including 92 bp upstream from the start codon (thereby including
its ribosome binding site) was amplified by PCR with primers
PMRBSD (59-TACAGGATCCGCTTGCCAGCCTCC-
GAATTGAC-39) and PMRBSR (59-
GGAATTCGCCTGTGCCCGCTCACTTCACG-39). The
PCR product was digested with both BamHI and EcoRI and
ligated into the same sites of pIB139 (Am
R, pUC18 replicon,
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pimM under the control of the constutive promoter ermE*, and
includes the original ribosome binding site of pimM, was then
transferred by conjugation from E. coli ET12567 [pUZ8002] to the
S. natalensis DPimR2 mutant as previously described [42].
Supporting Information
Figure S1 Gene complementation of S. natalensis
DpimR2 mutant restores pimaricin biosynthesis. Quan-
tification of the pimaricin production attained by the comple-
mented strain after 60 and 84 hours of growth. Data are the
average of three flasks. Vertical bars indicate the standard
deviation values.
(TIF)
Figure S2 Purification of GST-fusion protein in E.coli
BL21. Purification of GST-PimR
SARP by affinity chromatography
on Glutathione Sepharose. Lane T, total E. coli cell extract; lane P,
purified proteins after affinity chromatography. Left lane,
molecular size markers (in kDa).
(TIF)
Figure S3 Primer efficiency. The efficiency of each set of
primers was calculated according to the equation E=10
[21/
slope]21. Using 5-fold dilutions of genomic DNA, the resulting Ct
values were plotted against the logarithm of the DNA quantity as
shown in A (primers for pimM), B (primers for pimR) and C
(primers for rrnA1). Data are from three replicates and values
represent the mean 6 SD. Panel D summarizes information
obtained from each plot.
(TIF)
Table S1 Primers used in 59 RACE experiments.
(DOC)
Table S2 Primers used in quantitative real-time PCR
experiments.
(DOC)
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